Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Methods: The study cohort included a consecutive series of patients without AIDS and malignancy or organ transplantation who were assessed at a single institution for a first episode of PCP infection. Medical records were examined to determine underlying immunosuppressive disorders, corticosteroid dosage, associated infections, and subsequent respiratory failure and in-hospital mortality.
Conclusion: In this large consecutive series, systemic administration of corticosteroid therapy, even in the moderate doses may increase susceptibility to PCP infections. Consideration should be given to instituting PCP prophylaxis (when not contraindicated) in patients for whom prolonged systemic corticosteroid therapy is prescribed.
To cite this abstract in AMA style:Raheel S, Matteson EL, Crowson CS, Limper A, Carmona Porquera EM, Specks U, Baqir M. Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/pneumocystis-jirovecii-pneumonia-in-systemic-autoimmune-inflammatory-diseases/. Accessed May 22, 2019.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/pneumocystis-jirovecii-pneumonia-in-systemic-autoimmune-inflammatory-diseases/